JPRN-UMIN000031353尚未招募未知
Efficacy of zoledronic acid hydrate on glucocorticoids-induced osteoporosis for patients with autoimmune hepatitis - Zoledronic acid hydrate and autoimmune hepatitis
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with Child-Pugh score 11 points or more 2. Patients who received bisphosphonates or denosumab within 3 years prior to this study 3. Patients with a history of hypersensitivity to the ingredients of study drugs or other bisphosphonates 4. Patients with severe renal dysfunction (creatinine clearance <35ml/min) 5. Patients with dehydration state caused by high grade fever, severe diarrhea and vomiting. 6. Patients with hypocalcemia. 7. Pregnant patients or patients who are expected to be pregnant 8. Patients with severe comorbid diseases. Severe comorbid diseases indicate advanced malignancies, severe infection and bed rest state which can affect the interpretation for data of bone density. 9. Patients who are judged to be ineligible for the study subjects by investigators.
研究者
相似试验
已完成
Unknown
A new study to minimise the side effects of rapid maxillary expansioSide effects of rapid maxillary expansion (RME) on dental and buccal alveolar bone changesOral HealthISRCTN16744226Damascus University32
已完成
2 期
Additive effect of zoledronic acid on hormone-sensitive prostate cancer patients with bone metastasis treated by hormonal therapy: a prospective, multicenter studyProstate cancerJPRN-UMIN000010765Department of Urology, Saitama Medical Center, Saitama Medical University100
已完成
3 期
Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced OsteoporosisOsteoporosisNCT00100620Novartis Pharmaceuticals802
尚未招募
2 期
Effect of Zoledronic acid for Stage D2 hormone-sensitive prostate cancer patients.Prostate CancerJPRN-UMIN000002577Department of Urology, Keio University School of Medicine96
进行中（未招募）
1 期
Short term biological study effects of Zoledronate and Letrozole on invasive breast cancer - Short term effects (preoperative) of Femara and Zometa or Femara aloneBreast CancerEUCTR2004-004223-36-GBSouth Manchester University Hospital110